UTHR
United Therapeutics Corporation
472.20$
-3.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.9% | +10.2% | +5.5% | +4.8% | -1.7% | +7.9% | +0.5% | +0.1% | -1.2% | -1.1% | +0.2% | – | |
| – | +1.3% | +2.7% | +6.7% | +6.8% | -8.7% | +21.9% | -5.3% | +15.2% | +2.5% | +29.0% | -25.4% | – | |
| – | +0.8% | +11.2% | +5.3% | +4.5% | -0.9% | +6.3% | +1.3% | -1.7% | -1.7% | -5.6% | +5.5% | – | |
| – | +78.7% | -31.2% | +34.1% | -25.9% | +29.3% | +11.4% | -10.1% | -4.9% | +9.4% | -0.9% | +5.9% | – | |
| – | +1.1% | +12.1% | +25.6% | +30.4% | -31.7% | +5.9% | +11.4% | -3.9% | +2.3% | -1.1% | -11.3% | – | |
| – | +33.6% | -12.4% | +27.6% | +1.7% | -6.3% | +5.6% | +8.6% | -10.7% | +6.5% | -2.1% | +9.5% | – | |
| – | -20.5% | +37.0% | -10.2% | +7.3% | +4.3% | +7.0% | -4.8% | +6.8% | -8.2% | -8.9% | +1.5% | – | |
| – | -3.2% | -11.9% | -12.8% | -12.9% | -21.8% | -22.8% | +19.7% | -58.9% | +3.3% | -3.2% | -3.3% | – | |
| – | -16.0% | +34.9% | -10.9% | +9.4% | +2.0% | +6.8% | -3.6% | +7.2% | +1.4% | -28.3% | +17.1% | – | |
| – | -7.0% | +17.5% | -16.1% | +3.0% | +19.7% | +6.4% | -2.4% | +0.4% | -19.7% | -45.5% | -8.5% | – | |
| – | -18.9% | +41.2% | -9.3% | +11.1% | -2.5% | +6.9% | -3.9% | +9.4% | +7.6% | -24.5% | +21.1% | – | |
| – | -14.8% | +31.7% | -9.7% | +8.4% | +1.5% | +3.1% | -0.1% | +6.0% | +1.5% | -26.8% | +9.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.